Skip to main content

Month: August 2021

Aprea Therapeutics Announces Clinical Hold on Lymphoid Malignancy Program

BOSTON, Aug. 12, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, today announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on its clinical trial evaluating eprenetapopt with acalabrutinib or with venetoclax and rituximab in lymphoid malignancies. No additional patients can be enrolled until the clinical hold is resolved, though patients on study deriving clinical benefit can continue to receive study treatment. Subsequent to receiving notification of a partial clinical hold on its myeloid malignancies program, Aprea was informed by FDA of a clinical hold on its lymphoid malignancy study. The FDA’s concerns referred to the safety and...

Continue reading

Inflection Resources Identifies New Drill Targets – Acquires New Ground In Northern New South Wales

Figure 1Northern NSW Project – Exploration License and Application mapFigure 2Aeromagnetic (Reduced to pole) map of the Duck Creek principal target area of interest – High amplitude curvilinear magnetic patterns are interpreted to represent a kilometre-scale intrusive complexFigure 3Ginghet North (ELA6314) & Walgett East (ELA6315) Exploration License Applications. Total magnetic intensity, RTP airborne magnetic (left), residual gravity (right) data.VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) — Inflection Resources Ltd. (CSE: AUCU) (FSE: 5VJ) (OTCQB: AUCUF) (the “Company” or “Inflection”) is pleased to announce it has identified a number of new, priority copper-gold exploration targets in Northern New South Wales, Australia. The Company...

Continue reading

TLC Reports Second Quarter 2021 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 12, 2021 (GLOBE NEWSWIRE) — TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced financial results for the second quarter ended June 30, 2021 and provided a business update. “The second quarter of 2021 was marked mainly by the timely approval of our liposomal amphotericin B product in India and the immediate partnerships for their commercialization and sales in the territory,” commented George Yeh, President of TLC. “We are grateful to have the ability to be of assistance in this humanitarian crisis brought about by the COVID-19 pandemic by fulfilling an unmet need, and will continue our quest to provide best-in-class treatments in pain management, ophthalmology, oncology, as well as infectious...

Continue reading

Interim report – second quarter of 2021

Thursday, Schouw & Co. released its interim report for the second quarter of 2021; strong Q2 performance with 13% revenue and 8% EBITDA improvements despite challenging supply situation, higher prices of raw materials and sharply increased freight costs. Good demand in a number of important product areas. HighlightsStrong Q2 performance with revenue and EBITDA improving Good demand in a number of important product areas Challenging situation with prices of raw materials and transport costs spiking Reliability of supply takes priority over short-term optimisation Guidance raised for full-year revenue and EBITDAStatement by Jens Bjerg Sørensen, President of Schouw & Co. “Schouw & Co. builds on the momentum of its recent improvements in revenue and earnings. We are seeing the benefits of recent years’ investments in production...

Continue reading

Drawdown of a Loan Advance and Issue of Warrants Pursuant to Financing Arrangement Between Valoe Corporation and Riverfort and Payment of Implementation Fee in Shares

Valoe Corporation                Stock Exchange Release 12 August 2021 at 11.55 Finnish time Valoe Corporation (“Valoe” or the “Company”) has, pursuant to the terms and conditions of the financing arrangement between Valoe and RiverFort Global Opportunities Pcc Limited (“RiverFort”) announced on 30 July 2021 (“Financing Arrangement”), withdrawn the first advance totaling EUR 2,000,000 and issued to RiverFort in total 5,587,121 warrants related thereto. Valoe pays, pursuant to the terms and conditions of the Financing Arrangement, an implementation fee for the first advance totaling EUR 180,000 in the Company’s shares and will transfer a total of 2,011,363 treasury shares to RiverFort. After the transfer, the Company will have in total 23,840,031 treasury shares. In Mikkeli, 12 August 2021 Valoe Corporation BOARD OF DIRECTORS For...

Continue reading

Conversion of Convertible Bond 1/2020 Loan Shares Into Shares in Valoe Corporation. Conversion of Promissory Note Issued by Valoe Corporation to ISC Bioheat Oy into Shares.

Valoe Corporation                Stock Exchange Release 12 August 2021 at 11.50 Finnish time The Board of Directors of Valoe Corporation (the “Company”) has today resolved to partially convert the loan shares of the Company’s convertible bond 1/2020 into the Company’s shares and partially pay the loan shares in cash. Based on the conversion request submitted to the Company by the promissory note holder, BOD Global Group SIA (“BOD”), EUR 300,000 of the Convertible Bond 1/2020 capital and interest on the entire loan capital will be converted into Company shares and the Company will transfer a total of 4,521,524 treasury shares to BOD. EUR 100,000 of the Convertible Bond 1/2020 capital is paid to BOD in cash. The terms of the Convertible Bond 1/2021 were disclosed as stock exchange release on 23 July 2020. The subscription...

Continue reading

Cartel Blue, Inc. Announces First Ever Premium Hemp Cigar Lounges and Product Showrooms

Club 662Club 662Maui HempMaui HempMusic CityMusic CityClub HarleyClub HarleyCBD HydrateCBD HydrateSalesSalesLONG BEACH, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) — Cartel Blue, Inc. a Nevada Corporation founded in 1992, announced that an Agreement in Principle to commence with design, construction and managing of the first three new CARTEL Premium Cigar Lounges. Cartel Blue, Inc., announced the build out of the next three locations in Nashville, TN, followed by Cathedral City, CA, and the third location in Honolulu, HI. The new Hemp locations allow the Premium Hemp smoker to enjoy the Cartel products in a comfortable and secure setting. Company CEO, Philip Moreb believes purchasers of these high-quality Cigars should be allowed to...

Continue reading

Real People Investment Holdings Limited: Outcome of Shareholders’ meeting

The 2021 annual general meeting (“AGM”) of shareholders of Real People Investment Holdings Limited (“RPIH” or “the Company”) was held on Friday, 6 August 2021 at 12:30 CET, at which the shareholders approved the following resolutions. The meeting was held via video conference, without physical presence. Business of the meetingThe Company’s audited consolidated annual financial statements for the year ended 31 March 2021, including the Directors’ report, the Audit Committee report and the report of the independent auditors was presented. Re-appointment of the independent auditors and appointment of the designated auditorThe AGM resolved that Deloitte & Touché Inc. South Africa be re-appointed as auditors of the Company to hold office until the conclusion of the next annual general meeting of the Company, and that Llewellyn Marshall,...

Continue reading

Decisions of the extraordinary general meeting of shareholders of Arco Vara AS

The annual general meeting of shareholders of Arco Vara AS was held on 12 August 2021 in Maakri street 19/1 II floor, 10145 Tallinn, Estonia. The notice of calling the extraordinary general meeting was published in the information system of the stock exchange on 20 July 2021 (https://view.news.eu.nasdaq.com/view?id=be32996a710ca6ea2ef7013e3ff5b21be&lang=en), on Arco Vara AS’s website (https://www.arcorealestate.com/en/investor-relations/stock-exchange-news) and in a daily national newspaper „Eesti Päevaleht“ on 21 July 2021.         A total of seven shareholders attended the meeting representing 6,555,253 votes, which means 69.82% of the total votes were represented. The meeting therefore had a quorum. The decision of the extraordinary general meeting was as follows: Increase of the share capital in relation to the public offering...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.